
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CVS | NYSE | USD | Real-time | |
CVS | BIVA | MXN | Delayed | |
CVS | Mexico | MXN | Delayed | |
CVS | TradeGate | EUR | Delayed | |
CVS | Frankfurt | EUR | Delayed | |
CVS | Santiago | USD | Delayed | |
CVSCL | Santiago | CLP | Delayed | |
CVSH34 | BM&FBovespa | BRL | Delayed | |
CVS | Vienna | EUR | Real-time | |
CVS | Lima | USD | Delayed |
Period Ending: | 2023 30/06 |
2023 31/03 |
2022 31/12 |
2022 30/09 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 88647 | 84944 | 83523 | 80958 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 75318 | 71903 | 70033 | 67784 | ||||||||||||||||||||||||||||||
Gross Profit | 13329 | 13041 | 13490 | 13174 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 85034 | 81483 | 79721 | 77389 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 3613 | 3461 | 3802 | 3569 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | - | -349 | -237 | -2480 | ||||||||||||||||||||||||||||||
Other, Net | 1043 | 931 | 930 | 10505 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 2570 | 2879 | 3109 | -4456 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 656 | 737 | 809 | -1047 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 1914 | 2142 | 2300 | -3409 | ||||||||||||||||||||||||||||||
Minority Interest | 276 | 198 | 300 | 328 | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 1901 | 2136 | 2302 | -3416 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | 1901 | 2136 | 2302 | -3416 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | 1901 | 2136 | 2302 | -3416 | ||||||||||||||||||||||||||||||
Dilution Adjustment | -3.76 | 5.85 | 1.38 | 3 | ||||||||||||||||||||||||||||||
Diluted Net Income | 1904.76 | 2130.15 | 2300.62 | -3419 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 1287 | 1291 | 1319 | 1315 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | 1.48 | 1.65 | 1.74 | -2.6 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | 0.605 | 0.605 | 0.55 | 0.55 | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 1.56 | 1.56 | 1.63 | 1.54 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review